argenx to Present at Upcoming Investor Conferences
June 01 2022 - 1:00AM
June
1, 2022Breda, the
Netherlands – argenx (Euronext & Nasdaq: ARGX), a
global immunology company committed to improving the lives of
people suffering from severe autoimmune diseases, today announced
that members of management will participate in several upcoming
investor conferences in June:
- Jefferies 2022 Global
Healthcare Conference. Fireside chat on Wednesday, June 8,
2022 at 1:00 p.m. ET in New York, NY.
- Goldman Sachs
43rd Annual Global Healthcare
Conference. Fireside chat on Wednesday, June 15, 2022 at
3:20 p.m. PT in Rancho Palos Verdes, CA.
- JMP Securities Life
Sciences Conference. Management will participate in
investor meetings on Wednesday, June 15, 2022 in New York, NY.
Additional information regarding these events
will be available on the Investors section of the argenxwebsite at
argenx.com/investors.
About argenx
argenx is a global immunology company committed to improving the
lives of people suffering from severe autoimmune diseases.
Partnering with leading academic researchers through its Immunology
Innovation Program (IIP), argenx aims to translate immunology
breakthroughs into a world-class portfolio of novel antibody-based
medicines. argenx developed and is commercializing the
first-and-only approved neonatal Fc receptor (FcRn) blocker in the
U.S. and Japan. The Company is evaluating efgartigimod in multiple
serious autoimmune diseases and advancing several earlier stage
experimental medicines within its therapeutic franchises. For more
information, visit www.argenx.com and follow us on LinkedIn,
Twitter, and Instagram.
For further information, please contact:
Media:
Kelsey Kirkkkirk@argenx.com
Investors:
Beth DelGiaccobdelgiacco@argenx.com
Michelle Greenblattmgreenblatt@argenx.com
argenx (NASDAQ:ARGX)
Historical Stock Chart
From Jun 2024 to Jul 2024
argenx (NASDAQ:ARGX)
Historical Stock Chart
From Jul 2023 to Jul 2024